Anti-nausea drug, aprepitant, lowers risk of death from aggressive breast cancer by 39% 💊💖. In women with aggressive triple-negative breast cancer, aprepitant use was associated with a 34% reduced risk of metastasis and a 39% lower risk of death from breast cancer.
Read Full Article
#BreastCancerAwareness #Aprepitant #TripleNegativeBC #CancerResearch #HealthAdvancements
Read Full Article
#BreastCancerAwareness #Aprepitant #TripleNegativeBC #CancerResearch #HealthAdvancements
New Atlas
Anti-nausea drug lowers risk of death from aggressive breast cancer by 39%
A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive breast cancers live longer, cutting the risk of death by up to 39% in some cases, according to a new study.
🤔2